APA (7th ed.) Citation

KL, P., CA, R., IC, S., PO, V., D, B., HJ, M., . . . RJ, P. (2026). Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy. Molecular therapy. Advances, 34(2), 201757. https://doi.org/10.1016/j.omta.2026.201757

Chicago Style (17th ed.) Citation

KL, Poulin, et al. "Extracellular Vesicles as Biomarkers of Disease Progression and Therapeutic Response in Patients with Spinal Muscular Atrophy." Molecular Therapy. Advances 34, no. 2 (2026): 201757. https://doi.org/10.1016/j.omta.2026.201757.

MLA (9th ed.) Citation

KL, Poulin, et al. "Extracellular Vesicles as Biomarkers of Disease Progression and Therapeutic Response in Patients with Spinal Muscular Atrophy." Molecular Therapy. Advances, vol. 34, no. 2, 2026, p. 201757, https://doi.org/10.1016/j.omta.2026.201757.